Filing Details

Accession Number:
0001415889-24-008033
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-14 18:00:17
Reporting Period:
2024-03-12
Accepted Time:
2024-03-14 18:00:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1798749 Aerovate Therapeutics Inc. AVTE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413006 A George Eldridge C/O Aerovate Therapeutics, Inc.
930 Winter Street, Suite M-500
Waltham MA 02451
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-12 2,051 $2.14 4,011 No 4 M Direct
Common Stock Disposition 2024-03-12 2,051 $25.05 1,960 No 4 S Direct
Common Stock Acquisiton 2024-03-13 2,016 $2.14 3,976 No 4 M Direct
Common Stock Disposition 2024-03-13 2,016 $25.02 1,960 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-03-12 2,051 $0.00 2,051 $2.14
Common Stock Stock Option (Right to Buy) Disposition 2024-03-13 2,016 $0.00 2,016 $2.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
53,279 2031-04-01 No 4 M Direct
51,263 2031-04-01 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.08, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.